ScienceScience Now

Alzheimer's disease drugs disappointing

Diseases and IllnessesAlzheimer's Disease
In two large clinical trials, two separate biological therapies developed as treatments for Alzheimer's disease, solanezumab and bapineuzumab, failed to bring improvements in patients with the disease. Charles Dharapak / Associated Press
This photo is featured in these articles:
Loading